Botswana govt struggles with drug supply

19 March 2007

In an attempt to improve access to essential drugs, the government of the southern African nation of Botswana is preparing amendments to its Drugs and Related Substances Act, according to the Mmegi, a Gaborone-based newspaper.

Health Minister Sheila Tiou told Botswana's Parliament that "drug availability at Central Medical Stores and hospitals has been a serious challenge over the years." As a result, the government has announced a review of the CMS' operations by the Directorate of Public Service Management and German drugmaker Boeringer Ingelheim. The provision of security, following major problems of pilfering drug supplies, has been privatized.

Ms Tiou also told Parliament that the shortage of qualified pharmacists was affecting the effectiveness of health care provision in Botswana, with "inefficient drug management in clinics, hospitals and CMS often leading to drug shortages, expiries and congestion."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight